News
XBI
--
0.00%
--
Boston Scientific to acquire Preventice Solutions for $925 million in cash, up to $300 million in potential milestone payments
Boston Scientific Inc. undefined said Thursday it has agreed to acquire privately held Preventice Solutions Inc. for an upfront payment of $925 million and...
MarketWatch · 1d ago
DJ Boston Scientific To Acquire Preventice Solutions For $925million In Cash, Up To $300 Million In Potential Milestone Payments -- MarketWatch
Dow Jones · 1d ago
UPDATE: Bionano Genomics prices $200 million underwritten stock offering at a discount of $6 a share
Bionano Genomics Inc. undefined priced a $200 million underwritten stock offering announced late Tuesday at a discount of $6 a share, selling 33.3 million...
MarketWatch · 2d ago
DJ Bionano Genomics Prices $200 Million Underwritten Stock Offering At A Discount Of $6 A Share -- MarketWatch
Dow Jones · 2d ago
Biotech ETFs: More diversified funds reduce risk – Barron’s
Given the difficulty in stock picking in the biotech space, the investors are better off with more diversified ETFs focused on the industry, according to an article in the latest issue
Seekingalpha · 6d ago
DJ BioNTech To Target Supply Of Up To 2 Billion Doses Of COVID-19 Vaccine In 2021 -- MarketWatch
Dow Jones · 01/11 13:42
Bionano Genomics prices offering of 29 million shares at discount of $3.05 a share
Bionano Genomics Inc. undefined said Friday it has priced an underwritten public offering of 29 million shares at $3.05 a share. The stock closed Thursday at...
MarketWatch · 01/08 13:52
Pfizer and BioNTech say COVID-19 vaccine neutralizes mutation found in new U.K., South Africa variants
Pfizer Inc. undefined and German partner BioNTech SE undefined said Friday an in vitro study found that their COVID-19 vaccine neutralizes the two new highly...
MarketWatch · 01/08 11:45
ETF Areas Thriving During Coronavirus Pandemic
Zacks.com · 01/07 18:48
Citing uncertainty, Baird stays neutral on Biotech for 2021
Heading into 2021, Baird keeps a neutral view on Biotechnology despite higher expectations after the sector with a 26% gain in the iShares Nasdaq Biotechnology ETF (IBB) outperformed in 2020
Seekingalpha · 01/04 21:40
Moderna to provide Korea with 40 million doses of its COVID vaccine
Moderna Inc. undefined on Thursday confirmed that it has agreed to supply the South Korean government with 40 million doses of its COVID-19 vaccine....
MarketWatch · 12/31/2020 14:26
Pfizer and BioNTech to supply additional 100 million COVID vaccine doses to EU in 2021
Pfizer Inc. undefined and its German partner BioNTech SE undefined will supply an additional 100 million doses of their COVID-19 vaccine to the 27 member...
MarketWatch · 12/29/2020 18:31
Pfizer and BioNTech to supply additional 100 million COVID vaccine doses to EU in 2021
Pfizer Inc. undefined and its German partner BioNTech SE undefined will supply an additional 100 million doses of their COVID-19 vaccine to the 27 member...
MarketWatch · 12/29/2020 18:31
Myovant shares soar 27% on news of Pfizer prostate cancer drug collaboration worth up to $4.2 billion
Shares of Myovant Sciences soared 27% Monday, after its parent Sumitovant Biopharma unveiled an agreement with Pfizer Inc. to jointly develop a treatment for...
MarketWatch · 12/28/2020 17:01
Novavax starts Phase 3 COVID vaccine trial with plans to enroll 30,000 volunteers in U.S. and Mexico
Novavax Inc. undefined said Monday it is starting a late-stage trial of its COVID-19 vaccine candidate with plans to enroll up to 30,000 volunteers at about...
MarketWatch · 12/28/2020 14:31
The Jealousy List, ETF Edition
Subscribe to Trillions on Apple PodcastsSubscribe to Trillions on Spotify
Bloomberg · 12/24/2020 09:00
India Stocks Rise, Trimming First Weekly Loss Since October
India’s stocks rose on the last trading day of the week, trimming the benchmark’s first weekly loss in eight, as investors favored prospects for economic growth against risks posed by a new virus strain.
Bloomberg · 12/24/2020 04:53
High-Flying Crypto Fund Dumps XRP With Ripple in SEC ‘Hot Water’
Bloomberg · 12/23/2020 18:28
Flash Surge in World’s Biggest ETF Linked to ‘Outlandish’ Trades
Bloomberg · 12/23/2020 17:43
SPDR S&P Biotech ETF declares quarterly distribution of $0.1760
SPDR S&P Biotech ETF (XBI) - $0.1760.30-Day SEC Yield of 0.25% as of Dec. 18.Payable Dec 24; for shareholders of record Dec 22; ex-div Dec 21.
Seekingalpha · 12/21/2020 20:42
Webull provides a variety of real-time XBI stock news. You can receive the latest news about SPDR® S&P Biotech ETF through multiple platforms. This information may help you make smarter investment decisions.